Citadel Advisors’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $571K | Sell |
|
|||||
|
2023
Q4 | $986K | Sell |
|
|||||
|
2023
Q3 | $1.48M | Sell |
|
|||||
|
2023
Q2 | $3.29M | Buy |
|
|||||
|
2023
Q1 | $6.71M | Sell |
|
|||||
|
2022
Q4 | $6.73M | Buy |
|
|||||
|
2022
Q3 | $13.1M | Sell |
|
|||||
|
2022
Q2 | $14.2M | Sell |
|
|||||
|
2022
Q1 | $12.8M | Buy |
|
|||||
|
2021
Q4 | $19.9M | Sell |
|
|||||
|
2021
Q3 | $26.6M | Sell |
|
|||||
|
2021
Q2 | $30.3M | Sell |
|
|||||
|
2021
Q1 | $41M | Buy |
|
|||||
|
2020
Q4 | $52.3M | Buy |
|